Minimize Side Effects While Injecting Restylane Vital Light

restylane vital light image box
  • Only for use by authorized personnel in accordance with local legislation.
  • Not for intravascular injection. Injection into blood vessels could potentially cause vascular occlusion (blood vessel blockage), ischemia (restriction of blood supply0, and necrosis (tissue death).
  • Not for use in patients with bleeding disorders or who are taking thrombolytics or anticoagulants.
  • Do not resterilize.
  • Do not mix this gel with other products before injection.
  • Injections carry an infection risk. Use aseptic technique and standard practice to prevent cross-infections.
  • To avoid perforating or compressing blood vessels, nerves, and other vulnerable structures, you should use special caution and have knowledge of the area's anatomy.
  • Use caution when treating areas close to a permanent implant.
  • Use special caution when treating areas with limited collateral circulation. There is an increased risk of ischemia (restriction of blood supply).
  • Use special caution in patients who have had rhinoplasty since the vascular supply may be affected.
  • Use special caution when treating areas of the face with limited soft tissue support or cover, such as the periorbital area. Treatment in these areas may cause palpable lumps to form.
  • This skinbooster is not suitable for the lower periorbital region of those with pre-existing dark lower eye lid circles, thin skin, or a tendency to form edema (swelling).
  • Not for use in areas with active disease near the treatment site, including inflammation, infection, or tumors.
  • Injection can reactivate latent or subclinical herpes viral infections.
  • Patients are at an increased risk of bruising or bleeding at the injection site if they are using substances affecting platelet formation, such as aspirin or non-steroidal anti-inflammatory drugs.
  • Patients are unsuitable for treatment if they have unattainable expectations.
  • Do not use if product package is damaged.
  • Do not inject into an area with a non-hyaluronic acid implant.
  • Patients should avoid excessive sun and extreme cold until swelling and redness have resolved.
  • There is a risk of inflammatory reaction if this treatment is followed by laser, chemical peeling, or another treatment based on active dermal response. The same is true of injections before the skin has fully healed after one of these procedures.
  • Do not inject too large of a volume or inject too superficially since this may cause temporary palpable lumpiness.
  • Not tested in pregnant women.
  • Not tested in breastfeeding women.
  • Not tested in children.
  • Use the provided 29 G TW needles or a sterile blunt 30 G cannula. Size and length affect force required, and if you use a thinner cannula, the resistance may be too high. This increases risk for leakage or separation of cannula and syringe.
  • Do not reuse. There is a risk of contamination.

Note on articles: These articles are not endorsed by DoctorMedica nor reviewed for medical accuracy. Similarly, views and opinions expressed are those of the author only. Articles are meant for informational purposes only. Ask your doctor for professional medical advice.


Contact us
Mon-Fri 9am to 6pm EST
Email info@doctormedica.co
Phone 1-866-343-2413
Fax 1-888-793-2862